Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 1/2022

01-02-2022 | Computed Tomography | Case Report

Curative resection of ureteral metastasis of rectal cancer: a case report and review of literature

Authors: Yuki Matsui, Madoka Hamada, Yuki Matsumi, Mitsugu Sekimoto, Mitsuaki Ishida, Hironaga Satake, Hiroaki Kurokawa, Hidefumi Kinoshita

Published in: Clinical Journal of Gastroenterology | Issue 1/2022

Login to get access

Abstract

The metastasis to the ureter in colorectal cancer had been recognized at the stage of an autopsy. These days, according to the progression of diagnostic modalities, a few cases of long-time survival after curative surgery of metastatic ureteral tumor of colorectal cancer were reported. We present a case of a metastatic ureteral tumor of rectal cancer who had 32 months of recurrence-free survival after extirpation. After preoperative chemoradiotherapy, a 47-year-old man underwent laparoscopic low anterior resection and left unilateral pelvic node dissection for lower rectal cancer. He underwent several metastasectomies for recurrent tumors in the liver and lung. At the 42nd postoperative month, a contrast-enhanced CT scan showed thickening of the ureteral wall and left hydronephrosis. Transureteroscopic biopsy revealed metastatic adenocarcinoma of rectal cancer. At the 52nd postoperative month, partial ureteral resection and vesicoureteral neo-anastomosis were performed after confirming negative resection margin with rapid intraoperative pathology. He has 32 months of recurrence-free survival after metastasectomy of the left ureter. We review the literature presenting surgery of the metastatic ureteral tumor of colorectal cancer. Although it is a rare recurrence pattern, curative resection of ureteral metastasis might provide a possibility of long-time recurrence-free survival in such patients.
Literature
1.
go back to reference Cohen WM, Freed SZ, Hasson J. Metastatic cancer to the ureter: a review of the literature and case presentations. J Urol [Internet]. 1974;112:188–9.CrossRef Cohen WM, Freed SZ, Hasson J. Metastatic cancer to the ureter: a review of the literature and case presentations. J Urol [Internet]. 1974;112:188–9.CrossRef
2.
go back to reference Darrad M, Harper S, Verghese A, et al. Synchronous and metachronous ureteric metastases from adenocarcinoma of the colon. Int J Clin Oncol. 2012;17:185–8.CrossRef Darrad M, Harper S, Verghese A, et al. Synchronous and metachronous ureteric metastases from adenocarcinoma of the colon. Int J Clin Oncol. 2012;17:185–8.CrossRef
3.
go back to reference Aghalarov I, Förster S, Tannapfel A, et al. A double metachronous ureter metastasis following curative resection of rectal cancer. Case Rep Gastroenterol. 2021;15:450–5.CrossRef Aghalarov I, Förster S, Tannapfel A, et al. A double metachronous ureter metastasis following curative resection of rectal cancer. Case Rep Gastroenterol. 2021;15:450–5.CrossRef
4.
go back to reference Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma. J Anus Rectum Colon. 2019;3:175–95.CrossRef Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma. J Anus Rectum Colon. 2019;3:175–95.CrossRef
6.
go back to reference Stow B. Fibrolymphosarcomata of both ureters metastatic to a primary lymphosarcomata of the anterior mediastinum of thymus origin. Ann Surg [Internet]. 1909;50:901–6.CrossRef Stow B. Fibrolymphosarcomata of both ureters metastatic to a primary lymphosarcomata of the anterior mediastinum of thymus origin. Ann Surg [Internet]. 1909;50:901–6.CrossRef
7.
go back to reference Fitch WP, Robinson JR, Radwin HM. Metastatic carcinoma of the ureter. Arch Surg. 1976;111:874–6.CrossRef Fitch WP, Robinson JR, Radwin HM. Metastatic carcinoma of the ureter. Arch Surg. 1976;111:874–6.CrossRef
8.
go back to reference Richie JP, Withers G, Ehrlich RM. Ureteral obstruction secondary to metastatic tumors. Surg Gynecol Obstet. 1979;148:355–7.PubMed Richie JP, Withers G, Ehrlich RM. Ureteral obstruction secondary to metastatic tumors. Surg Gynecol Obstet. 1979;148:355–7.PubMed
9.
go back to reference Hudolin T, Nola N, Milas I, et al. Ureteral metastasis of occult breast cancer. Breast. 2004;13:530–2.CrossRef Hudolin T, Nola N, Milas I, et al. Ureteral metastasis of occult breast cancer. Breast. 2004;13:530–2.CrossRef
10.
go back to reference Shimoyama Y, Ohashi M, Hashiguchi N, et al. Gastric cancer recognized by metastasis to the ureter. Gastric Cancer. 2000;3:102–5.CrossRef Shimoyama Y, Ohashi M, Hashiguchi N, et al. Gastric cancer recognized by metastasis to the ureter. Gastric Cancer. 2000;3:102–5.CrossRef
11.
go back to reference Bisof V, Juretic A, Pasini J, et al. Ureteral metastasis as the first and sole manifestation of gastric cancer dissemination. Radiol Oncol [Internet]. 2010;44:262–4. Bisof V, Juretic A, Pasini J, et al. Ureteral metastasis as the first and sole manifestation of gastric cancer dissemination. Radiol Oncol [Internet]. 2010;44:262–4.
12.
go back to reference Mackenzie DW, Ratner M. Metastatic growths of the ureter: a brief review of the literature and a report of three cases. Br J Urol [Internet]. 1932;4:27–35.CrossRef Mackenzie DW, Ratner M. Metastatic growths of the ureter: a brief review of the literature and a report of three cases. Br J Urol [Internet]. 1932;4:27–35.CrossRef
14.
go back to reference Presman D, Ehrlich L. Metastatic tumors of the ureter. J Urol. 1948;59:312–25.CrossRef Presman D, Ehrlich L. Metastatic tumors of the ureter. J Urol. 1948;59:312–25.CrossRef
15.
go back to reference Nikolaos F, Panagiotis A, Konstantinos B, et al. Distant ureteral metastasis from colon adenocarcinoma: report of a case and review of the literature. Case Rep Urol. 2014;2014:1–4.CrossRef Nikolaos F, Panagiotis A, Konstantinos B, et al. Distant ureteral metastasis from colon adenocarcinoma: report of a case and review of the literature. Case Rep Urol. 2014;2014:1–4.CrossRef
16.
go back to reference Peifer D, Rohloff M, Maatman T. A rare case of metastatic sigmoid adenocarcinoma to the ureter. Urol Case Rep. 2019;26:1–3. Peifer D, Rohloff M, Maatman T. A rare case of metastatic sigmoid adenocarcinoma to the ureter. Urol Case Rep. 2019;26:1–3.
17.
go back to reference Moynihan MJ, Moinzadeh A, Mandeville JA. Symptomatic ureteral metastasis from colon adenocarcinoma. J Endourol Case Rep. 2020;6:80–2.CrossRef Moynihan MJ, Moinzadeh A, Mandeville JA. Symptomatic ureteral metastasis from colon adenocarcinoma. J Endourol Case Rep. 2020;6:80–2.CrossRef
18.
go back to reference Ibrahim A, Hirschfeld S, Cohen MH, et al. FDA drug approval summaries: oxaliplatin. Oncologist. 2004;9:8–12.CrossRef Ibrahim A, Hirschfeld S, Cohen MH, et al. FDA drug approval summaries: oxaliplatin. Oncologist. 2004;9:8–12.CrossRef
19.
go back to reference Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386–422.CrossRef Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386–422.CrossRef
Metadata
Title
Curative resection of ureteral metastasis of rectal cancer: a case report and review of literature
Authors
Yuki Matsui
Madoka Hamada
Yuki Matsumi
Mitsugu Sekimoto
Mitsuaki Ishida
Hironaga Satake
Hiroaki Kurokawa
Hidefumi Kinoshita
Publication date
01-02-2022
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 1/2022
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01568-3

Other articles of this Issue 1/2022

Clinical Journal of Gastroenterology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.